Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Doctors raise concerns about administration's Part B drug plan
A CMS Fact Sheet on the ANPRM International Pricing Index Model for Medicare Part B Drugs
Key clinical point: A proposed Trump administration plan for paying for drugs under Medicare Part B has raised red flags for doctors.
Major finding: The Centers for Medicare & Medicaid Services announced that it will test paying for Part B drugs by more closely aligning those payments with international rates.
Disclosures: None.
Citation:
A CMS Fact Sheet on the ANPRM International Pricing Index Model for Medicare Part B Drugs